
Results
2
2 companies
MedinCell
Market Cap: €879.8m
A clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.
MEDCL
€24.50
7D
-5.6%
1Y
53.3%
DBV Technologies
Market Cap: €688.3m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.33
7D
-1.0%
1Y
34.0%